Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells.
| dc.contributor.author | Garcia-Alegria, Eva | |
| dc.contributor.author | Menegatti, Sara | |
| dc.contributor.author | Batta, Kiran | |
| dc.contributor.author | Cuvertino, Sara | |
| dc.contributor.author | Florkowska, Magdalena | |
| dc.contributor.author | Kouskoff, Valerie | |
| dc.date.accessioned | 2016-08-17T09:25:18Z | |
| dc.date.available | 2016-08-17T09:25:18Z | |
| dc.date.issued | 2016-07-12 | |
| dc.identifier.citation | Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells. 2016: FEBS Lett. | en |
| dc.identifier.issn | 1873-3468 | |
| dc.identifier.pmid | 27404333 | |
| dc.identifier.doi | 10.1002/1873-3468.12300 | |
| dc.identifier.uri | http://hdl.handle.net/10541/618466 | |
| dc.description.abstract | Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells. | |
| dc.language | ENG | |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to FEBS letters | en |
| dc.title | Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells. | en |
| dc.type | Article | en |
| dc.contributor.department | Cancer Research UK Stem Cell Haematopoiesis Group, Cancer Research UK Manchester | en |
| dc.identifier.journal | FEBS Letters | en |
| html.description.abstract | Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells. |